ALD-25F

N/A

Report date: 2025/01/26 17:49:05

Base Information

Drug NameALD-25F

Drug Alias Namedual Teff stimulator/Treg modulator (Alderaan Biotechnology)Treg-depleting/Teff-stimulating anti-CD25 antibody/IL-15 fusion protein (Alderaan Biotechnology)CD25mAb-IL-15ALD-25F

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionInterleukin-2 receptor alpha chain modulatorsInterleukin-15 receptors replacement

TargetsInterleukin-15 receptorsInterleukin-2 receptor alpha chain

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAlderaan Biotechnology SAS

China Registration ClassN/A

Develop Information

Active CompaniesAlderaan Biotechnology SAS

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A